Novozymes A/S (NVZMF)
OTC: NVZMF
· Real-Time Price · USD
67.38
0.00 (0.00%)
At close: Aug 12, 2025, 3:54 PM
Novozymes A/S Cash Flow Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 186M | 241.9M | 238.32M | 238.33M | 695M | 929M | 614M | 801M | 877M | 1.15B | 817M | 839M | 623M | 843M | 794M | 885M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | 263M | 332M | 335M | 357M | 370M | 377M | 377M | 361M | 345M | 353M | 378M | 340M |
Stock-Based Compensation | n/a | n/a | n/a | n/a | 152M | n/a | n/a | n/a | 102M | n/a | n/a | n/a | 111M | n/a | n/a | n/a |
Other Working Capital | -260.8M | 76.4M | 725.77M | 725.8M | 211M | -10M | 6M | 6M | -7M | -2M | -8M | -435M | 165M | -184M | 266M | -303M |
Other Non-Cash Items | 181.2M | 173.5M | 1.01B | 1.01B | -117M | 106M | 111M | 38M | -326M | -196M | 241M | 430M | 18M | 599M | 555M | 357M |
Deferred Income Tax | n/a | n/a | n/a | n/a | -298M | n/a | n/a | n/a | -472M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -260.8M | 76.4M | 725.77M | 725.8M | 427M | 219M | 70M | -882M | 33M | -114M | -8M | -494M | 54M | -332M | 10M | -344M |
Operating Cash Flow | 106.4M | 491.8M | 1.97B | 1.97B | 1.12B | 1.59B | 1.13B | 314M | 584M | 1.22B | 1.43B | 775M | 695M | 1.11B | 1.36B | 898M |
Capital Expenditures | -55.2M | -212.1M | -504.23M | -504.26M | -604M | -475M | -549M | -428M | -900M | -756M | -844M | -390M | -599M | -228M | -218M | -195M |
Cash Acquisitions | n/a | 66.5M | 56.69M | 56.69M | -77M | -11M | -158M | 88M | 2M | 267M | -22M | -55M | -870M | 1M | -8M | -753M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 7.1M | -8.2M | 242.79M | 242.8M | 78M | -38M | 2M | 1M | 199M | 25M | -31M | 1M | 121M | 1M | 1M | 1M |
Investing Cash Flow | -38.3M | -144.8M | -204.75M | -204.76M | -603M | -486M | -705M | -339M | -898M | -464M | -866M | -444M | -1.35B | -227M | -225M | -947M |
Debt Repayment | -86.5M | -218.3M | -80.7M | -106.3M | 381M | -954M | -136M | 1.43B | -167M | -401M | -49M | 942M | 537M | -653M | -216M | 908M |
Common Stock Repurchased | -30.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -360M | -140M | n/a | -368M | -848M | -284M |
Dividend Paid | n/a | -124.9M | -465.82M | -465.84M | -1.19B | n/a | -1M | -1.66B | n/a | n/a | -1M | -1.52B | n/a | n/a | -1M | -1.47B |
Other Financial Acitivies | n/a | -2.8M | -208M | -926.84M | 257M | 1.41B | -328.62M | 264M | 134M | -13M | -257M | 480M | 105M | -25M | -151M | 694M |
Financial Cash Flow | -102.1M | -329.8M | -1.39B | -89.9M | -555M | -977M | -456M | 99M | 23M | -414M | -667M | -192M | 692M | -988M | -1.22B | -74M |
Net Cash Flow | -30.5M | 19.2M | 414.35M | 63.1M | -59M | 127M | -52M | 59M | -336M | 364M | -84M | 134M | 100M | -106M | -94M | -118M |
Free Cash Flow | 51.2M | 279.7M | 1.47B | 1.47B | 518M | 1.11B | 581M | -114M | -316M | 464M | 583M | 385M | 96M | 882M | 1.14B | 703M |